Capecitabine 154361-50-9 pharmaceutical intermediates
Capecitabine is an antimetabolic fluoropyrimidine deoxynucleoside carbamate drug that can be converted into 5-FU in vivo. It is developed by Roche company and its trade name is Xeloda. It can inhibit cell division and interfere with RNA and protein synthesis.
It is suitable for the further treatment of paclitaxel and advanced primary or metastatic breast cancer including anthracycline antibiotic chemotherapy.
It is mainly used in the treatment of advanced primary or metastatic breast cancer, rectal cancer, colon cancer and gastric cancer.
New oral fluoropyrimidines
Anticancer drugs are mainly used in non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer and other solid tumors
COMPANY INTRODUCTION
JIN DUN CHEMICAL belongs to JIN DUN GROUP. It is a professional enterprise dedicated to the development and production of special (meth)acrylate monomers. The head office is located in Shanghai city, near Hongqiao airport.The R&D center of JIN DUN is located in Ningbo city, Zhejiang province.
JIN DUN CHEMICAL focus on the coating, automobile, electricity and pharmaceutical area, always try best to be the professional supplier of new raw material for the advanced material in coating, automobile chemicals, electricity chemicals and pharmaceutical intermediate.
The EU company of JIN DUN CHEMICAL located at Frankfurt in Germany. It makes us service our customer better in EU, but also takes more valued information for our creation and future developing.
Welcome our customers and friends to visit our company.
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View